Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 4
1997 15
1998 57
1999 59
2000 140
2001 182
2002 177
2003 205
2004 227
2005 232
2006 238
2007 237
2008 263
2009 238
2010 252
2011 243
2012 269
2013 262
2014 276
2015 261
2016 240
2017 227
2018 251
2019 237
2020 313
2021 301
2022 310
2023 290
2024 96

Text availability

Article attribute

Article type

Publication date

Search Results

5,311 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial.
Bartels SAL, Donker M, Poncet C, Sauvé N, Straver ME, van de Velde CJH, Mansel RE, Blanken C, Orzalesi L, Klinkenbijl JHG, van der Mijle HCJ, Nieuwenhuijzen GAP, Veltkamp SC, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JWS, Belkacemi Y, Petignat P, Schinagl DAX, Coens C, van Tienhoven G, van Duijnhoven F, Rutgers EJT. Bartels SAL, et al. J Clin Oncol. 2023 Apr 20;41(12):2159-2165. doi: 10.1200/JCO.22.01565. Epub 2022 Nov 16. J Clin Oncol. 2023. PMID: 36383926 Clinical Trial.
PURPOSE: The European Organisation for Research and Treatment of Cancer 10981-22023 AMAROS trial evaluated axillary lymph node dissection (ALND) versus axillary radiotherapy (ART) in patients with cT1-2, node-negative breast cancer …
PURPOSE: The European Organisation for Research and Treatment of Cancer 10981-22023 AMAROS trial evaluated axillary lymph n
Axillary surgery in breast cancer: An updated historical perspective.
Magnoni F, Galimberti V, Corso G, Intra M, Sacchini V, Veronesi P. Magnoni F, et al. Semin Oncol. 2020 Dec;47(6):341-352. doi: 10.1053/j.seminoncol.2020.09.001. Epub 2020 Oct 23. Semin Oncol. 2020. PMID: 33131896 Free article. Review.
Axillary lymph-node dissection (ALND) has been replaced by sentinel lymph-node biopsy (SLNB) in women with early clinically node-negative breast cancer, providing adequate axillary nodal staging informat
Axillary lymph-node dissection (ALND) has been replaced by sentinel lymph-node biopsy
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group. Tinterri C, et al. Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215. Br J Surg. 2023. PMID: 37471574 Free PMC article. Clinical Trial.
RESULTS: A total of 218 patients were treated with mastectomy; 111 were randomly assigned to the axillary lymph node dissection group and 107 to the sentinel lymph node biopsy-only group. At a median follow-up of 33.0 months …
RESULTS: A total of 218 patients were treated with mastectomy; 111 were randomly assigned to the axillary lymph node
Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Che Bakri NA, Kwasnicki RM, Khan N, Ghandour O, Lee A, Grant Y, Dawidziuk A, Darzi A, Ashrafian H, Leff DR. Che Bakri NA, et al. Ann Surg. 2023 Apr 1;277(4):572-580. doi: 10.1097/SLA.0000000000005671. Epub 2022 Aug 10. Ann Surg. 2023. PMID: 35946806 Free PMC article.
OBJECTIVE: To evaluate the impact of axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB) on upper limb (UL) morbidity in breast cancer patients. BACKGROUND: Axillary de-escalation is mot …
OBJECTIVE: To evaluate the impact of axillary lymph node dissection (ALND) and sentinel lymph n
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview.
Vázquez JC, Piñero A, de Castro FJ, Lluch A, Martín M, Barnadas A, Alba E, Rodríguez-Lescure Á, Rojo F, Giménez J, Solá I, Quintana MJ, Bonfill X, Urrutia G, Sánchez-Rovira P. Vázquez JC, et al. Clin Transl Oncol. 2022 Sep;24(9):1744-1754. doi: 10.1007/s12094-022-02824-9. Epub 2022 Apr 12. Clin Transl Oncol. 2022. PMID: 35414152 Review.
PURPOSE: We conducted a systematic review to analyse the performance of the sentinel lymph-node biopsy (SLNB) after the neoadjuvant chemotherapy, compared to axillary lymph-node dissection, in terms of false-negative rate (F …
PURPOSE: We conducted a systematic review to analyse the performance of the sentinel lymph-node biopsy (SLNB) af …
Re-sentinel node biopsy after previous breast and axillary surgery.
Ikeda T. Ikeda T. Surg Today. 2014 Nov;44(11):2015-21. doi: 10.1007/s00595-013-0783-2. Epub 2013 Nov 20. Surg Today. 2014. PMID: 24254062 Review.
There is no consensus regarding the strategy for managing the regional lymph nodes in patients with local breast cancer recurrence. This paper reviews the updated data on re-sentinel lymph node biopsy (re-SLNB) after previous surgery. ... …
There is no consensus regarding the strategy for managing the regional lymph nodes in patients with local breast cancer recurr …
Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review.
Lovrics O, Tao B, Parvez E. Lovrics O, et al. Curr Oncol. 2023 Mar 7;30(3):3102-3110. doi: 10.3390/curroncol30030235. Curr Oncol. 2023. PMID: 36975448 Free PMC article. Review.
Landmark trials (Z0011 and AMAROS) have demonstrated that axillary lymph node dissection (ALND) can be safely omitted in patients with breast cancer and 1-2 positive sentinel nodes. Extrapolating from these and other cardinal studies such …
Landmark trials (Z0011 and AMAROS) have demonstrated that axillary lymph node dissection (ALND) can be safely om …
Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
Barrio AV, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D, Cody HS 3rd, El-Tamer M, Gemignani ML, Heerdt A, Kirstein L, Moo TA, Pilewskie M, Plitas G, Sacchini V, Sclafani L, Tadros A, Van Zee KJ, Morrow M. Barrio AV, et al. JAMA Oncol. 2021 Dec 1;7(12):1851-1855. doi: 10.1001/jamaoncol.2021.4394. JAMA Oncol. 2021. PMID: 34617979 Free PMC article.
IMPORTANCE: Prospective trials have demonstrated sentinel lymph node (SLN) false-negative rates of less than 10% when 3 or more SLNs are retrieved in patients with clinically node-positive breast cancer rendered clinically node-negative w …
IMPORTANCE: Prospective trials have demonstrated sentinel lymph node (SLN) false-negative rates of less than 10% when 3 …
Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.
Janni W, Kühn T, Schwentner L, Kreienberg R, Fehm T, Wöckel A. Janni W, et al. Dtsch Arztebl Int. 2014 Apr 4;111(14):244-9. doi: 10.3238/arztebl.2014.0244. Dtsch Arztebl Int. 2014. PMID: 24766712 Free PMC article. Review.
BACKGROUND: Increasing evidence suggests that surgical removal of the axillary lymph nodes (axillary dissection, ALD) in early breast cancer yields no advantage in terms of either overall or disease-free survival, even in women with involvement …
BACKGROUND: Increasing evidence suggests that surgical removal of the axillary lymph nodes (axillary dissection, …
The role of axillary reverse mapping in intraoperative nodal palpation during sentinel lymph node biopsy.
Noguchi M, Morioka E, Noguchi M, Inokuchi M, Kurose N, Shioya A, Yamada S. Noguchi M, et al. Breast J. 2021 Aug;27(8):651-656. doi: 10.1111/tbj.14260. Epub 2021 Jun 13. Breast J. 2021. PMID: 34120393
Patients with clinically negative nodes underwent sentinel lymph node biopsy with intraoperative nodal palpation and axillary reverse mapping. ...Fluorescent nodes were considered axillary reverse mapping nodes. Patients with positive …
Patients with clinically negative nodes underwent sentinel lymph node biopsy with intraoperative nodal palpation …
5,311 results